Pityriasis Rubra Pilaris-Like Reaction Induced by a Tyrosine Kinase Inhibitor, the Ponatinib

Am J Dermatopathol. 2021 May 1;43(5):394-395. doi: 10.1097/DAD.0000000000001822.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology
  • Humans
  • Imidazoles / adverse effects*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Pityriasis Rubra Pilaris / chemically induced*
  • Pityriasis Rubra Pilaris / pathology
  • Protein Kinase Inhibitors / adverse effects*
  • Pyridazines / adverse effects*

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Protein Kinase Inhibitors
  • Pyridazines
  • ponatinib